The use of primidone in the treatment of refractory bipolar disorder

Annals of Clinical Psychiatry

Volumn 11, Issue 2, 1999, Pages 61-66

  Schaffer, Linda C ^a,d   Schaffer, Charles B ^b   Caretto, Jaime ^c  

^a Sutler Community Hospitals   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

Anticonvulsants; Bipolar disorder; Primidone; Treatment

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; CLORAZEPATE; DESIPRAMINE; DIAZEPAM; DOXEPIN; FLURAZEPAM; GABAPENTIN; LAMOTRIGINE; LITHIUM; NEFAZODONE; PRIMIDONE; QUETIAPINE; TEMAZEPAM; TIOTIXENE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HALLUCINATION; HUMAN; MAINTENANCE THERAPY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NAUSEA; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; AMBULATORY CARE; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; PRIMIDONE; PROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0032837029     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022338330606     Document Type: Article

References (42)

1. Takesazi H, Hanoaka M: The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic depressive states. Clin Psychiatry 1971; 13:173-182
2. Ballenger JC, Post RM: Therapeutic effects of carbamazepine in affective illness: A preliminary report. Commun Psychopharmacol 1978; 2:159-175
3. Grossi E, Sacchetti E, Vita A, Conte G, Faravelli C, Hautman G, Zerbi D, Mesina AM, Drago F, Motta A: Carbamazepine vs. chlorpromazine in mania: A double-blind trial. In: Emrich HM, Okuma T, Muller AA, eds. Anticonvulsants in Affective Disorders. Amsterdam: Excerpta Medica; 1984:177-187
4. Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA: Carbamazepine versus haloperidol for the treatment of acute manic episodes. Abstract presented at the 149th annual meeting of the American Psychiatric Association, New York, May 1996
5. Lerer B, Moore N, Meyendoff E, Cho SR, Gershon S: Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987; 48:89-93
6. Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, Mori A, Watanabe M: Comparison of the antimanic efficacy of carbamazepine. Psychopharmacology (Berl) 1979; 66:211-217
7. Post RM, Ballanger JC, Uhde TW, Bunney WE: Efficacy of carbamazepine in manic-depressive illness: implications for underlying mechanisms. In: Post RM, Ballanger JC, eds. Neurobiology of Mood Disorders. Baltimore: Williams & Wilkins; 1984:77-816
8. Small JG, Klapper MH, Milstein V, Kellams JJ, Miller JD, Marhenke JD, Small IF: Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991; 48:915-921
9. Lambert PA, Cavaz G, Borselli S, Carbel S: Action neuropsychotrope d'un nouvel anti-epilptique: le Depamide. Ann Med Psychol (Paris) 1966; 1:707-710
10. Emrich HM, Dose M, von Zerssen D: The use of sodium valproate, carbamazepine, and oxcarbamazepine in patients with affective disorders. J Affect Disord 1985; 8:243-250
11. Brennan MJW, Sandyk R, Borsook D: Use of sodium valproate in the management of affective disorders: basic and clinical aspects. In: Emrich HM, Okuna T, Muller AA, eds. Anticonvulsans in Affective Disorders. Amsterdam: Excerpta Medica; 1984:56-65
12. Post RM, Berettini W, Uhde TW, Kellner C: Selective response to the anticonvulsant carbamazepine in manic depressive illness: A case study. J Clin Psychopharmacol 1984; 4:178-185
13. Pope HG Jr, McEIroy SL, Keck PE Jr, Hudson JI: Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991; 48:62-68
14. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC: A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108-111
15. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG: Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994; 271:918-924
16. McElroy SL, Keck PE Jr, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM: A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996; 57:142-146
17. Schaffer CB, Schaffer LC: Gabapentin in the treatment of bipolar disorder [letter]. Am J Psychiatry 1997; 154:291-292
18. Stanton SP, Keck PE Jr, McElroy SL: Treatment of acute mania with gabapentin. Am J Psychiatry 1997; 154:287
19. Ryback RS, Brodsky L, Munasifi F: Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci 1997; 9:301
20. McEIroy SL, Soutullo CA, Keck PE Jr, Kmetz GF: A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997; 9:99-103
21. Stanton SP, Keck PE, McElroy SL: Treatment of acute mania with gabapentin. Am J Psychiatry 1997; 154:287
22. Knoll J, Stegman K, Suppes T: Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998; 49:229-233
23. Ghaemi SN, Katzow JJ, Deai SP, Goodwin FK: Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry 1998; 59:426-429
24. Erfuth A, Kammerer C, Grunze H, Normann C, Walden J: An open label study of gabapentin in the treatment of acute mania. J Psychiatry Res 1998; 32:261-264
25. Frye MA, Ketter TA, Dunn RT, Speer AS, Osuch EA, CoraLocatelli G, Post RE: Lamotrigine vs. gabapentin monotherapy in unipolar and bipolar illness. Presented at151rst annual meeting of the American Psychiatric Association, Toronto, May 1998
26. Walden J, Hesslinger B, van Calker D, Berger M: Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996; 29:193-195
27. Calabrese JR, Fatemi SH, Woyshville MJ: Antidepressant effects of lamotrigine in rapid cycling bipolar disorder [letter]. Am J Psychiatry 1996; 153:1236
28. Fatemi SH, Rapport DJ, Calabrese JR, Thuras P: Lamotrigine in rapid cycling bipolar disorder. J Clin Psychiatry 1997; 58:522-527
29. Kusumaker V, Yatham LN: Lamotrigine treatment of rapid cycling bipolar disorder [letter]. Am J Psychiatry 1997; 154: 1171-1172
30. Fogelson DL, Sternbach H: Lamotrigine treatment of refractory bipolar disorder. J Clin Psychiatry 1997; 58:271-273
31. Sporn J, Sachs G: The anticonvulsant lamotrigine in the treatment-resistant manic-depressive illness. J Clin Psychiatry 1997; 17:185-189
32. Labbate LA, Rubey RN: Lamotrigine for treatment-refractory bipolar disorder [letter]. Am J Psychiatry 1997; 154:1317
33. Kusumaker V, Yatham LN: An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997; 72: 145-148
34. Kotler M. Matar MA: Lamotrigine in trie treatment of resistant bipolar disorder. Clin Neuropharmacol 1998; 21:65-66
35. Brown GM, Stone GH, Rathbone MP: Primidone and rapid cycling affective disorders. Lancet 1993; 342:925
36. Hayes SG: Barbiturate anticonvulsants in refractory affective disorders. Ann Clin Psychiatry 1993; 5:35-44
37. American Psychiatric Association: DSM-IV. Washington, DC: APA: 1994
38. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151 (Dec Suppl):5-12
39. Bowden CL: Treatment of bipolar disorder. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1998:734-735
40. Expert Consensus Guideline Series: Treatment of Bipolar Disorder. J Clin Psychiatry 1996; 57:Suppl 12 A
41. Engel J: Seizures and Epilepsy (Contemporary Neurology Series). Philidelphia: F. A. Davis; 1989:412
42. Post RM, Uhde TW, Putnam FW, Ballenger JC, Berrettini WH: Kindling and carbamazepine in affective illness. J Nerv Ment Dis 1982; 120:717-731